Trial Outcomes & Findings for Propofol for Pediatric Tracheal Intubation With Deep Anesthesia During Sevoflurane Induction (NCT NCT01150838)

NCT ID: NCT01150838

Last Updated: 2021-02-08

Results Overview

Logistic regression utilized to measure the amount of propofol to obtain 50% excellent intubation conditions for each age/time group. The quality of tracheal intubation will be graded according to the Steyn modification of the Helbo-Hansen scoring system for tracheal intubation, which includes evaluation of ease of laryngoscopy, position of the vocal cords, coughing, jaw relaxation and movement of limbs, each evaluated on a 1-4 scale, with 1 being the best possible condition and 4 the worst. The intubation conditions will be classified as either excellent or not-excellent. "Excellent" will be defined as a total score of 5, a score of 1 for each category, and "not-excellent" will be a total score of 6-20, meaning a score of \>1 in any category. While the outcome measure of each intubation is "excellent" or "not excellent", the overall outcome being generated is the amount of propofol in mg/kg required for 50% excellent intubation score.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

106 participants

Primary outcome timeframe

Amount of time it takes to intubate each patient; approximate time is 15-45 seconds

Results posted on

2021-02-08

Participant Flow

Participants were recruited at an outpatient surgery center

Four patients dropped out due to protocol violations or ended up outside the three time periods by the time IV access obtained.

Participant milestones

Participant milestones
Measure
Age 1-6 Years, Time 2-4 Minutes of Sevoflurane Until Propofol Administration
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued until at least 6 "crossovers" are achieved.
Age 1-6 Years, Time 4-6 Minutes of Sevoflurane Until Propofol Administration
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued until at least 6 "crossovers" are achieved.
Age 1-6 Years, Time 6-8 Minutes of Sevoflurane Until Propofol Administration
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued until at least 6 "crossovers" are achieved.
Age 6-11 Years, Time 2-4 Minutes of Sevoflurane Until Propofol Administration
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued until at least 6 "crossovers" are achieved.
Age 6-11 Years, Time 4-6 Minutes of Sevoflurane Until Propofol Administration
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued until at least 6 "crossovers" are achieved.
Age 6-11 Years, Time 6-8 Minutes of Sevoflurane Until Propofol Administration
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued until at least 6 "crossovers" are achieved.
Overall Study
STARTED
19
26
24
15
16
2
Overall Study
COMPLETED
19
26
24
15
16
2
Overall Study
NOT COMPLETED
0
0
0
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

No sex/gender data was collected.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Age 1-6 Years, Time 2-4 Minutes of Sevoflurane Until Propofol Administration
n=19 Participants
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued. propofol: Initial dose: Propofol 2 mg/kg, then dose changes separately based on the last subject in the same age group and sevo time range
Age 1-6 Years, Time 4-6 Minutes of Sevoflurane Until Propofol Administration
n=26 Participants
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued. propofol: Initial dose: Propofol 2 mg/kg, then dose changes separately based on the last subject in the same age group and sevo time range
Age 1-6 Years, Time 6-8 Minutes of Sevoflurane Until Propofol Administration
n=24 Participants
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued. propofol: Initial dose: Propofol 2 mg/kg, then dose changes separately based on the last subject in the same age group and sevo time range
Age 6-11 Years, Time 2-4 Minutes of Sevoflurane Until Propofol Administration
n=15 Participants
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued. propofol: Initial dose: Propofol 2 mg/kg, then dose changes separately based on the last subject in the same age group and sevo time range
Age 6-11 Years, Time 4-6 Minutes of Sevoflurane Until Propofol Administration
n=16 Participants
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued. propofol: Initial dose: Propofol 2 mg/kg, then dose changes separately based on the last subject in the same age group and sevo time range
Total
n=100 Participants
Total of all reporting groups
Age, Categorical
<=18 years
19 Participants
n=19 Participants
26 Participants
n=26 Participants
24 Participants
n=24 Participants
15 Participants
n=15 Participants
16 Participants
n=16 Participants
100 Participants
n=100 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=19 Participants
0 Participants
n=26 Participants
0 Participants
n=24 Participants
0 Participants
n=15 Participants
0 Participants
n=16 Participants
0 Participants
n=100 Participants
Age, Categorical
>=65 years
0 Participants
n=19 Participants
0 Participants
n=26 Participants
0 Participants
n=24 Participants
0 Participants
n=15 Participants
0 Participants
n=16 Participants
0 Participants
n=100 Participants
Sex: Female, Male
Female
0 Participants
No sex/gender data was collected.
Sex: Female, Male
Male
0 Participants
No sex/gender data was collected.
Region of Enrollment
United States
19 Participants
n=19 Participants
26 Participants
n=26 Participants
24 Participants
n=24 Participants
15 Participants
n=15 Participants
16 Participants
n=16 Participants
100 Participants
n=100 Participants

PRIMARY outcome

Timeframe: Amount of time it takes to intubate each patient; approximate time is 15-45 seconds

Population: Two patients in Age 6-11 years, 6-8 minutes, did not appear in baseline analysis population due to inadequate numbers collected in that age group and time range to be able to analyze; IV access always achieved earlier that 6 minutes due to ease of IV access.

Logistic regression utilized to measure the amount of propofol to obtain 50% excellent intubation conditions for each age/time group. The quality of tracheal intubation will be graded according to the Steyn modification of the Helbo-Hansen scoring system for tracheal intubation, which includes evaluation of ease of laryngoscopy, position of the vocal cords, coughing, jaw relaxation and movement of limbs, each evaluated on a 1-4 scale, with 1 being the best possible condition and 4 the worst. The intubation conditions will be classified as either excellent or not-excellent. "Excellent" will be defined as a total score of 5, a score of 1 for each category, and "not-excellent" will be a total score of 6-20, meaning a score of \>1 in any category. While the outcome measure of each intubation is "excellent" or "not excellent", the overall outcome being generated is the amount of propofol in mg/kg required for 50% excellent intubation score.

Outcome measures

Outcome measures
Measure
Age 1-6 Years, Time 2-4 Minutes of Sevoflurane Until Propofol Administration
n=19 Participants
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued until at least 6 "crossovers" are achieved.
Age 1-6 Years, Time 4-6 Minutes of Sevoflurane Until Propofol Administration
n=26 Participants
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued until at least 6 "crossovers" are achieved.
Age 1-6 Years, Time 6-8 Minutes of Sevoflurane Until Propofol Administration
n=24 Participants
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued until at least 6 "crossovers" are achieved.
Age 6-11 Years, Time 2-4 Minutes of Sevoflurane Until Propofol Administration
n=15 Participants
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued until at least 6 "crossovers" are achieved.
Age 6-11 Years, Time 4-6 Minutes of Sevoflurane Until Propofol Administration
n=16 Participants
Propofol 2 mg/kg administered to first subject. Dose will be increased by 0.3 mg/kg for the next subject if intubation score is "not excellent". Dose will be decreased by 0.3 mg/kg if intubation score is "excellent". This dosing scheme will be continued until at least 6 "crossovers" are achieved.
Estimated Propofol Doses Producing 50% Excellent Intubation Conditions
1.48 mg/kg
Interval 0.8 to 2.03
0.00 mg/kg
Interval 0.0 to 0.38
0.07 mg/kg
Interval 0.0 to 0.68
2.35 mg/kg
Interval 1.97 to 2.45
2.33 mg/kg
Interval 1.59 to 2.45

Adverse Events

Propofol Administration

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

George Politis MD

University of Virginia

Phone: 434-924-2283

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place